Trump Administration Asks Judge to Dismiss Lawsuit Seeking to Block Telehealth Access to Abortion Pill Mifepristone

The Trump administration has requested a judge dismiss a lawsuit filed by three Republican-led states that aims to restrict access to the abortion medication mifepristone through telehealth services. The administration’s action represents a legal challenge to the states’ efforts to limit how patients can obtain the drug. Specifically, the states’ lawsuit seeks to prevent individuals from receiving mifepristone via telehealth consultations, arguing that patients should be required to obtain the medication in person. In response, the Trump administration filed a motion asking the judge to throw out the case.

Newsflash | Powered by GeneOnline AI
Date: May 6, 2025

Related posts:

AI Revolutionizes Tuberculosis Treatment with New Drug Target Research Stanford Symposium: Biotech Executives Voice Concerns Over Scientific Ecosystem Challenges in Drug Discovery Ludwig Cancer Research: Humanized Antibody Developed to Disrupt Fat Uptake in Tumor Immune Cells Semaglutide Resolves MASH in 62.9% of Patients Without Worsening Fibrosis, Study Finds

Author

Mark Chiang

紐約 NYU Computer Science 碩士 紐澤西 UMDNJ Biomedical Informatics 博士 中研院博士後 台灣大學博士後